Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Jacobson

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Molecular and Cellular Cardiology|February 1, 1994
Modification of cardiac membrane adenylate cyclase activity and Gs alpha by NAD and endogenous ADP-ribosyltransferaseE E Quist, D L Coyle, R Vasan, et al.
Cancer Research|June 1, 1984
Effect of nicotinamide analogues on recovery from DNA damage in C3H10T1/2 cellsE L Jacobson, J Y Smith, M Mingmuang, et al.
Biochimie|January 1, 1995
NAD glycohydrolases and the metabolism of cyclic ADP-riboseM K Jacobson, D Cervantes-Laurean, M S Strohm, et al.
Cancer|April 15, 1991
Effect of hyperthermia in vitro and in vivo on adenine and pyridine nucleotide pools in human peripheral lymphocytesH I Robins, G G Jonsson, E L Jacobson, et al.
Molecular and Cellular Biology|June 1, 1995
trans-dominant inhibition of poly(ADP-ribosyl)ation sensitizes cells against gamma-irradiation and N-methyl-N'-nitro-N-nitrosoguanidine but does not limit DNA replication of a polyomavirus repliconJ H Küpper, M Müller, M K Jacobson, et al.
The AIDS Reader|November 18, 2000
Restoration of immunity with interleukin-2 therapyK A Smith, E L Jacobson, R Emert, et al.
The Journal of Biological Chemistry|November 7, 1998
Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymersW M Shieh, J C Amé, M V Wilson, et al.
Nature Medicine|November 2, 2001
Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivoS Partida-Sánchez, D A Cockayne, S Monard, et al.
HIV Clinical Trials|October 9, 2001
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trialJ P Lalezari, J A Beal, P J Ruane, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Molecular and Cellular Cardiology|February 1, 1994
Modification of cardiac membrane adenylate cyclase activity and Gs alpha by NAD and endogenous ADP-ribosyltransferaseE E Quist, D L Coyle, R Vasan, et al.
Cancer Research|June 1, 1984
Effect of nicotinamide analogues on recovery from DNA damage in C3H10T1/2 cellsE L Jacobson, J Y Smith, M Mingmuang, et al.
Biochimie|January 1, 1995
NAD glycohydrolases and the metabolism of cyclic ADP-riboseM K Jacobson, D Cervantes-Laurean, M S Strohm, et al.
Cancer|April 15, 1991
Effect of hyperthermia in vitro and in vivo on adenine and pyridine nucleotide pools in human peripheral lymphocytesH I Robins, G G Jonsson, E L Jacobson, et al.
Molecular and Cellular Biology|June 1, 1995
trans-dominant inhibition of poly(ADP-ribosyl)ation sensitizes cells against gamma-irradiation and N-methyl-N'-nitro-N-nitrosoguanidine but does not limit DNA replication of a polyomavirus repliconJ H Küpper, M Müller, M K Jacobson, et al.
The AIDS Reader|November 18, 2000
Restoration of immunity with interleukin-2 therapyK A Smith, E L Jacobson, R Emert, et al.
The Journal of Biological Chemistry|November 7, 1998
Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymersW M Shieh, J C Amé, M V Wilson, et al.
Nature Medicine|November 2, 2001
Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivoS Partida-Sánchez, D A Cockayne, S Monard, et al.
HIV Clinical Trials|October 9, 2001
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trialJ P Lalezari, J A Beal, P J Ruane, et al.
Pageof 5